Pain Medicine, Interventional Pain Medicine · Hoover, AL
NPI
1669608923
Since 2009
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
4515 Southlake Pkwy Ste 200
Hoover, AL, 35244
Phone (205) 313-7246
Groups this clinician bills Medicare through
Medicare paid, 2024
$321K
8,944 services
Medicare patients, 2024
352
Average age 68
Drug cost, 2024
$777K
11,045 prescriptions
Company payments, 2025
$4,075
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Roberto D Chang was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 1,854 times for 93 patients. In total Roberto D Chang billed 8,944 services in 60 codes, and Medicare paid $321K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-10-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,854 | 93 | $0.09 | $159 |
| 99213 Office E&M - Established | Office | 561 | 203 | $52.48 | $29K |
| 80307 Drug Tests | Office | 486 | 188 | $59.19 | $29K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 432 | 169 | $12.15 | $5,247 |
| 99214 Office E&M - Established | Office | 424 | 164 | $78.83 | $33K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 377 | 151 | $146.86 | $55K |
| J2704 Injection, propofol, 10 mg | Office | 198 | 11 | $0.10 | $18.91 |
| J2250 Injection, midazolam hydrochloride, per 1 mg | Office | 115 | 29 | $0.10 | $11.16 |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 75 | 35 | $192.33 | $14K |
| 63650 Neurostimulator - Back | Office | 72 | 34 | $1,134.04 | $82K |
| 01992 Anesthesia | Office | 53 | 38 | $69.23 | $3,669 |
| 64483 Nerve Block Injection - Back | Office | 50 | 36 | $192.42 | $9,621 |
| 62323 Nerve Block Injection - Back | Office | 49 | 36 | $143.86 | $7,049 |
| 99203 Office E&M - New | Office | 40 | 40 | $66.01 | $2,640 |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 38 | 29 | $109.50 | $4,161 |
By year: 2022 $293K for 5,840 services; 2023 $297K for 8,303 services; 2024 $321K for 8,944 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 486 | 188 | $59.19 | $29K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 377 | 151 | $146.86 | $55K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 75 | 35 | $192.33 | $14K |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 38 | 29 | $109.50 | $4,161 |
| 80053 Clinical Chemistry | 33 | 33 | $10.10 | $333 |
| 85025 Blood Count | 15 | 15 | $7.61 | $114 |
Medicare prescription drug claims, 2024
In 2024, the drug Roberto D Chang prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 1,783 prescriptions and refills. In total Roberto D Chang wrote 11,045 Medicare prescriptions that cost $777K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,783 | 1,783 | 278 | $53K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 1,637 | 1,643 | 286 | $67K |
| Gabapentin Generic | 1,049 | 1,237 | 220 | $14K |
| Tizanidine Hcl Generic | 764 | 926 | 151 | $8,583 |
| Oxycodone Hcl Generic | 521 | 521 | 101 | $11K |
| Pregabalin Generic | 461 | 508 | 78 | $18K |
| Morphine Sulfate Er Morphine Sulfate | 389 | 390 | 68 | $14K |
| Fentanyl Generic | 288 | 289 | 51 | $46K |
| Duloxetine Hcl Generic | 250 | 339 | 59 | $3,478 |
| Celecoxib Generic | 240 | 281 | 52 | $4,020 |
| Methocarbamol Generic | 238 | 272 | 69 | $3,865 |
| Cyclobenzaprine Hcl Generic | 226 | 266 | 56 | $2,321 |
| Trazodone Hcl Generic | 215 | 277 | 47 | $1,061 |
| Buprenorphine Generic | 199 | 199 | 38 | $51K |
| Meloxicam Generic | 199 | 242 | 43 | $894 |
Brand drugs: 593 claims; generic drugs: 10,452 claims; opioid claims: 5,586.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Roberto D Chang $4,075 ($4,075 in general payments such as food, travel and fees) from 14 companies. The largest payer was MML US, Inc. with $1,699.
| Company | Payments | Amount |
|---|---|---|
| MML US, Inc. | 9 | $1,699 |
| BIOTRONIK NRO, Inc. | 24 | $871 |
| Boston Scientific Corporation BSX | 38 | $711 |
| SPR Therapeutics, Inc | 9 | $165 |
| Spinal Simplicity, LLC | 4 | $144 |
| Forte Bio-Pharma LLC | 6 | $121 |
| Pfizer Inc. PFE | 5 | $120 |
| Collegium Pharmaceutical, Inc. COLL | 4 | $74.01 |
| Saluda Medical Americas, Inc. | 3 | $58.19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $39.9 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.